Zoetis inc stock.

tendered in exchange for 400,985,000 shares of common stock of Zoetis Inc. (“Zoetis”), representing all of the Zoetis stock then owned by Pfizer (the “Exchange”). Pursuant to the Exchange, tendering Pfizer shareholders received 0.9898 of a share of Zoetis common stock in exchange for each share of PfizerRead Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...PARSIPPANY, N.J., March 13, 2023 -- ( BUSINESS WIRE )-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business ...The estimated Net Worth of Paul Bisaro is at least $38.1 Million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,665,873 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.

tendered in exchange for 400,985,000 shares of common stock of Zoetis Inc. (“Zoetis”), representing all of the Zoetis stock then owned by Pfizer (the “Exchange”). Pursuant to the Exchange, tendering Pfizer shareholders received 0.9898 of a share of Zoetis common stock in exchange for each share of Pfizer

Overview Stock Screener Earnings Calendar Sectors NYSE | ZTS U.S.: NYSE Zoetis Inc. Watch list After Hours Last Updated: Nov 21, 2023 6:11 p.m. EST Delayed quote $ 178.72 -0.01 -0.01% After...

Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.May 5, 2022 · Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022. For Fourth Quarter 2021, Zoetis Reports Revenue of $2.0 Billion, Growing 9%, and Net Income of $414 Million, or $0.87 per Diluted Share, on a Reported Basis Reports Adjusted Net Income of $474 Million, or Adjusted Diluted EPS of $1.00, for Fourth Quarter 2021 Delivers 9% Operational Growth in Revenue and 5% Operational Growth in Adjusted Net …Zoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of $179.13 on volume of 907,604 shares. Over the past year the S&P 500 is up 14.06% while ZTS is up 17.12%. ZTS earned $4.92 a per share in the over the last 12 months, giving it a price-to ...

Idexx Laboratories Inc. (IDXX) Idexx, an animal veterinary products and services company, is on a tear in 2023. Its share price is up 34.2% year to date, to $547.47 as of July 18. The company is ...

Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...

Zoetis Declares Fourth Quarter 2021 Dividend. PARSIPPANY, N.J.-- (BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Wednesday, December 1, 2021, to holders of record on Friday, October ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Transcript : Zoetis Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01:00 PM. CI. Nov. 21. Zoetis Insider Sold Shares Worth …Zoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of $179.13 on volume of 907,604 shares. Over the past year the S&P 500 is up 14.06% while ZTS is up 17.12%. ZTS earned $4.92 a per share in the over the last 12 months, giving it a price-to ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...Explore all Zoetis Animal Health products for companion animal and livestock, as well as our innovative diagnostic solutions. Learn more.Zoetis Inc stock price live 176.63, this page displays NYSE ZTS stock exchange data. View the ZTS premarket stock price ahead of the market session or assess the after hours quote.Stock analysis for Zoetis Inc (1ZTS:BrsaItaliana) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Prior to her executive leadership at Zoetis, Ms. Driscoll served in roles of increasing responsibility at Procter & Gamble from 1994 to 2016. She established and led the company’s global business development group in Geneva, Switzerland, during her tenure as Executive Global Head for Europe, Corporate Global Business Development …Get the latest Zoetis Inc (ZOE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ...64.05%. Get the latest Zoetis Inc (ZTS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers ... Nov 13, 2023 · Zoetis Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Mexican Stock Exchange: ZTS ... The estimated Net Worth of Catherine A. Knupp is at least $17 Million dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,610,292 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President und President - Research …Zoetis Inc (ZTS). 175.79 -1.18 (-0.67%) USD | NYSE | Nov 29, 16:00. 175.33 ... Zoetis Stock Buybacks (Quarterly): 250.00M for Sept. 30, 2023. View 4,000+ ...View Zoetis Inc ZTS investment & stock information. Get the latest Zoetis Inc ZTS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ...Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.The company that owns Cummins diesel engines is Cummins Inc., a public company that is listed on the stock market. It is listed on the New York Stock Exchange, and most of its shares are owned by institutional shareholders.

Feb 14, 2023 · PARSIPPANY, N.J.-- (BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023. The company reported revenue of $2.0 billion for the fourth quarter of 2022, which was an increase of 4% compared with the fourth quarter of 2021.

Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ...

Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ... ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation.PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals.0.92%. $5.88B. ZTS | Complete Zoetis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Feb 15, 2023 · Zoetis shares rose 5.4% on Tuesday after Q4 2022 results showed its growth back on track. The P/E is now back to 35x. See why ZTS stock is a buy. What ETF is ZOETIS INC in? Information about cost, fund size and performance of the ETFs that contain this stock.Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ...

Zoetis Declares Fourth Quarter 2021 Dividend. PARSIPPANY, N.J.-- (BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Wednesday, December 1, 2021, to holders of record on Friday, October ...The average price point forecasted by analysts for Zoetis Inc (ZTS) is $222.04, which is $66.19 above the current market price. The public float for ZTS is 459.99M, and currently, short sellers hold a 0.65% ratio of that floaft. The average trading volume of ZTS on October 31, 2023 was 1.63M shares.Zoetis is a component of the S&P 500 and has roughly 13,800 employees. Analyst Report: Zoetis Inc Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and ...The intrinsic value of one ZTS stock under the Base Case scenario is 114.51 USD. Compared to the current market price of 179.13 USD, Zoetis Inc is Overvalued by ...Instagram:https://instagram. how to read the spreadgoogle solve math problemsvspmxok amazon Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel Türkiye utah medical products incbooks by john bogle The Dividend Yield % of Zoetis Inc (ZTS) is 0.84% (As of Today), Highest Dividend Payout Ratio of Zoetis Inc (ZTS) was 0.3. The lowest was 0.16. And the median was 0.19. The Forward Dividend Yield % of Zoetis Inc (ZTS) is 0.84%. For more information regarding to dividend, please check our Dividend Page .The estimated Net Worth of Catherine A. Knupp is at least $17 Million dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,683,611 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President and President - Research … where are goldbacks accepted The estimated Net Worth of William C Jr Steere is at least $5.98 Million dollars as of 20 May 2021. Mr. Steere owns over 16,170 units of Zoetis Inc stock worth over $5,651,123 and over the last 20 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc.Back to ZTS Overview. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...